会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • PHARMACEUTICAL COMPOSITIONS OF SOMATOSTATIN-DOPAMINE CONJUGATES
    • 生长抑素 - 多巴胺偶联物的药物组合物
    • WO2009139855A2
    • 2009-11-19
    • PCT/US2009/002943
    • 2009-05-12
    • IPSEN PHARMA S.A.S.DONG, Zheng, XinZHANG, Jundong
    • DONG, Zheng, XinZHANG, Jundong
    • A61K38/12
    • A61K38/31
    • The present invention is directed to improvements in compositions containing a somatostatin- dopamine conjugate which retains both somatostatin and dopamine activity in vivo, methods for preparing such compositions, and method of using such compositions to treat mammals. In particular, the present invention relates to a pharmaceutical composition comprising Dop2-DLys(Dop2)- cyclo[Cys-Tyr-DTrp-Lys-Abu-Cys]-Thr-NH 2 (SEQ ID NO: 1), in which the somatostatin-dopamine conjugate precipitates in vivo at physiological pH to form an in situ deposit that is slowly dissolved and released into the body fluid and bloodstream. The present invention may further comprise an organic component such as dimethylacetamide (DMA) or polyethylene glycol with an average molecular weight of 400 (PEG400).
    • 本发明涉及含有生长激素抑制素 - 多巴胺缀合物的组合物的改进,所述组合物在体内既保留生长激素抑制素又保持多巴胺活性,制备所述组合物的方法以及使用所述组合物治疗哺乳动物的方法。 具体而言,本发明涉及包含Dop2-DLys(Dop2) - 环[Cys-Tyr-DTrp-Lys-Abu-Cys] -Thr-NH2(SEQ ID NO: 1),其中生长激素抑制素 - 多巴胺缀合物在生理pH下在体内沉淀以形成缓慢溶解并释放到体液和血流中的原位沉积物。 本发明可进一步包含有机组分,如二甲基乙酰胺(DMA)或平均分子量为400的聚乙二醇(PEG400)。